RGOS
Asset Logo

Russell Sust Global Opportunities Complex ETF

๐Ÿ‡ฆ๐Ÿ‡บ ASX

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ“™ Holdings

๐Ÿ’ฐ Distributions

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

N/A
Annual Growth

5 years average annual growth

๐Ÿ’ฐ

4.38%
Annual distribution yield

Based on the most recent distribution

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

0
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

RGOS.AX was created on 2024-04-12 by Russell. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to outperform the Funds benchmark, before costs and tax, over the long term by providing exposure to a diversified portfolio of predominantly international shares.

๐ŸŒ Website

๐Ÿ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ“™ Top Holdings

Show more

Top holdings information is not yet available for this fund. For more information please visit the fund manager's website.

๐Ÿ’ฐ Distributions

Payouts

๐Ÿ’ฐ Annual Distribution Yield*

4.38%

๐Ÿ’ฐ Annual Distribution Earnings Per $1,000 invested**

$43.80

๐Ÿ’ฐ Most Recent Distribution Franked Percentage Estimate

0.20%

๐Ÿ’ฐ Average Distribution Franked Percentage Estimate

0.11 %

๐Ÿ’ฐ Distribution reinvestment

Learn more

* Based on the most recent distribution

** Calculated by multiplying the most recent distribution yield by $1,000

Estimate your distribution

If you held

$

of RGOS, your last distribution payment(s) would have been:

$ 14.88

on Mon Oct 14 2024

$ 411.75

on Mon Jul 15 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Distribution History

1Y

5Y

10Y

Graph

Table

Year
Yearly Distribution Earnings Per Share
Franking Estimate

2024

$0.88

0.10%

2023

$0.00

0.00%

2022

$0.00

0.00%

2021

$0.00

0.00%

2020

$0.00

0.00%

2019

$0.00

0.00%

2018

$0.00

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

2015

$0.00

0.00%

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$21.34

๐Ÿ’ฐ Price To Earnings Ratio

0.00

๐Ÿ’ฐ Price To Book Ratio

0.00

๐Ÿ’ฐ Leveraged

No

๐Ÿ’ฐ Inverse

No

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in RGOS

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in RGOS

N/A
RGOS investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in RGOS also invest in...

Want more shares? Try these...

Argent Biopharma Limited

RGT

Argent Biopharma Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2006-12-21. Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The firm is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.

๐Ÿ™Œ Performance (5Yr p.a)

127.06%

๐Ÿ“Š Share price

$0.25 AUD

๐Ÿ“ฆ LOGISTICS

Find Out More

Ramsay Health Care Ltd. engages in the healthcare services and the operation of hospitals and day surgery facilities. The company is headquartered in Sydney, New South Wales and currently employs 89,000 full-time employees. The Companyโ€™s segments include Asia Pacific, UK, France and Nordics. Its businesses include Ramsay Australia, Ramsay Sante, Ramsay UK, and Elysium Healthcare. Ramsay Australia has over 73 private hospitals and day surgery units in Australia. Ramsay Sante is a private care provider in Europe and operates 443 multidisciplinary hospitals and clinics and 130 primary care centers across five countries. Ramsay UK has a network of 34 acute hospitals and day procedure centers in England providing a comprehensive range of clinical specialties to private and self-insured patients. Elysium Healthcare is an independent sector provider of specialist health and care services. Its four core service streams are mental health, neurological, learning disabilities and children and education.

๐Ÿ™Œ Performance (5Yr p.a)

-9.22%

๐Ÿ“Š Share price

$39.05 AUD

๐Ÿ•Š๏ธ SOCIALLY AWARE

๐Ÿฉบ HEALTH CARE

๐Ÿƒ HIGH ESG SCORE

๐ŸŒณ ENVIRONMENTAL

Riversgold Ltd. engages in the exploration and development of mineral resources. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2017-10-10. The firm is focused on discovering and developing large lithium systems in the Pilbara and Yilgarn cratons of Western Australia. Its projects include Pilbara Lithium Projects, Southern Cross-Marvel Loch Lithium Project, Kurnalpi Region Projects, and South Australian Projects. The Pilbara Lithium Projects include Tambourah Project, Wodgina East and Upper Five Mile Creek. The Kurnalpi Project comprises 10 exploration licenses and one application. The company is located between 50 kilometers (km) and 120 km east to south-east of the regional mining center town of Kalgoorlie-Boulder in the Eastern Goldfields of Western Australia. The South Australian Projects include the Churchill Dam Iron-Oxide Copper-Gold Project, which is in the Gawler Craton, approximately 20 km west of Woomera and 90 km southwest of the giant Olympic Dam deposit in South Australia. The Upper Five Mile Creek Project is located over 20 km south-east of Nullagine.

๐Ÿ™Œ Performance (5Yr p.a)

-14.00%

๐Ÿ“Š Share price

$0.00 AUD

โ›๏ธ MINING

Region Group engages in the business of investing in and managing shopping centres. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-11-26. The firm is engaged in investing in a geographically diverse portfolio of convenience-based retail centers located across Australia. Its portfolio focuses on the non-discretionary retail sector (primarily convenience retailers and grocery outlets) and is anchored by long-term leases to tenants. The firm owns and manages approximately 92 convenience-based retail properties. The Companyโ€™s properties include Albury, Annandale Central, Auburn Central, AYR (Burdekin Plaza), Bakewell, Belmont Central, Bentons Square, Blakes Crossing, Brookwater Village, Burnie Plaza, Bushland Beach, Busselton, Cabarita, Cardiff, Central Highlands (Emerald), Chancellor Park Marketplace, Claremont Plaza, Cooloola Cove, Currambine Central, Delacombe Town Centre, Drayton Central, and Bentons Square, among others.

๐Ÿ™Œ Performance (5Yr p.a)

-3.96%

๐Ÿ“Š Share price

$2.15 AUD

๐Ÿ  REAL ESTATE

๐ŸŒณ ENVIRONMENTAL

Compare
Add to watchlist